US 9422339
Immunomodulating cyclic compounds
granted A61KA61K31/395A61K38/00
Quick answer
US patent 9422339 (Immunomodulating cyclic compounds) held by Aurigene Discovery Technologies Limited expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/395, A61K38/00, A61K38/12, A61K45/06